Literature DB >> 25918983

Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.

Linda Gao1, Karin van den Hurk2, Jérémie Nsengimana3, Jonathan P Laye3, Joost J van den Oord4, Samuel Beck5, Nelleke A Gruis1, Willem H Zoutman1, Manon van Engeland2, Julia A Newton-Bishop3, Véronique J Winnepenninckx2, Remco van Doorn6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25918983     DOI： 10.1038/jid.2015.163

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  16 in total

1.  Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer.

Authors:  Miguel Alvarez-Múgica; Virginia Cebrian; Jesus M Fernández-Gómez; Florentino Fresno; Safwan Escaf; Marta Sánchez-Carbayo
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

2.  Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.

Authors:  Caroline Conway; Angana Mitra; Rosalyn Jewell; Juliette Randerson-Moor; Samira Lobo; Jérémie Nsengimana; Sara Edward; D Scott Sanders; Martin Cook; Barry Powell; Andy Boon; Faye Elliott; Floor de Kort; Margaret A Knowles; D Timothy Bishop; Julia Newton-Bishop
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

3.  Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin.

Authors:  Yan Ping Yu; Jian-Hua Luo
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

4.  Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers.

Authors:  F Lin; Y P Yu; J Woods; K Cieply; B Gooding; P Finkelstein; R Dhir; D Krill; M J Becich; G Michalopoulos; S Finkelstein; J H Luo
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Authors:  Véronique Winnepenninckx; Vladimir Lazar; Stefan Michiels; Philippe Dessen; Marguerite Stas; Soledad R Alonso; Marie-Françoise Avril; Pablo L Ortiz Romero; Thomas Robert; Ovidiu Balacescu; Alexander M M Eggermont; Gilbert Lenoir; Alain Sarasin; Thomas Tursz; Joost J van den Oord; Alain Spatz
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

6.  Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.

Authors:  Linda Gao; Marjon A Smit; Joost J van den Oord; Jelle J Goeman; Els M E Verdegaal; Sjoerd H van der Burg; Marguerite Stas; Samuel Beck; Nelleke A Gruis; Cornelis P Tensen; Rein Willemze; Daniel S Peeper; Remco van Doorn
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-17       Impact factor: 4.693

7.  KIT is a frequent target for epigenetic silencing in cutaneous melanoma.

Authors:  Christina Dahl; Cecilie Abildgaard; Rikke Riber-Hansen; Torben Steiniche; Johanne Lade-Keller; Per Guldberg
Journal:  J Invest Dermatol       Date:  2014-09-01       Impact factor: 8.551

8.  Multiple isoforms of the tumor suppressor myopodin are simultaneously transcribed in cancer cells.

Authors:  Ariane De Ganck; Veerle De Corte; An Staes; Kris Gevaert; Joël Vandekerckhove; Jan Gettemans
Journal:  Biochem Biophys Res Commun       Date:  2008-03-25       Impact factor: 3.575

9.  Epigenetic disruption of cadherin-11 in human cancer metastasis.

Authors:  F Javier Carmona; Alberto Villanueva; August Vidal; Clara Muñoz; Sara Puertas; Rosa M Penin; Montserrat Gomà; Amaia Lujambio; Josep M Piulats; Ricard Mesía; Montse Sánchez-Céspedes; Manel Manós; Enric Condom; Suzanne A Eccles; Manel Esteller
Journal:  J Pathol       Date:  2012-07-26       Impact factor: 7.996

10.  Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells.

Authors:  Y-P Yu; J-H Luo
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867
View more
  3 in total

1.  A Cancer Associated Fibroblasts-Related Six-Gene Panel for Anti-PD-1 Therapy in Melanoma Driven by Weighted Correlation Network Analysis and Supervised Machine Learning.

Authors:  Luyao Tian; Fei Long; Youjin Hao; Bo Li; Yinghong Li; Ying Tang; Jing Li; Qi Zhao; Juan Chen; Mingwei Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-11

Review 2.  DNA methylation/hydroxymethylation in melanoma.

Authors:  Siqi Fu; Haijing Wu; Huiming Zhang; Christine G Lian; Qianjin Lu
Journal:  Oncotarget       Date:  2017-05-30

3.  Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway.

Authors:  Erjie Xia; Xiaofen Zhou; Adheesh Bhandari; Xiaohua Zhang; Ouchen Wang
Journal:  Cancer Manag Res       Date:  2018-06-18       Impact factor: 3.989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.